MEDICALLY REVIEWED

New Analyses on Lecanemab Suggest Sustained Benefits Even After Discontinuation

Dementia
In Asia Pacific, the number of people suffering from dementia is set to triple from 23 million in 2015 to 71 million by 2050.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: